Xcel Wealth Management’s Moderna MRNA Stock Holding History

Xcel Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.13M	Buy	+5,889	New	+$635K	0.28%	68
2023 Q3	–	Sell	-3,193	Closed	-$388K	–	124
2023 Q2	$388K	Sell	3,193 -20	-0.6%	-$2.67K	0.12%	99
2023 Q1	$493K	Buy	3,213 +147	+5%	+$24.2K	0.17%	86
2022 Q4	$551K	Buy	3,066 +50	+2%	+$8.18K	0.22%	76
2022 Q3	$357K	Buy	3,016 +640	+27%	+$97.1K	0.13%	93
2022 Q2	$339K	Sell	2,376 -900	-27%	-$129K	0.12%	95
2022 Q1	$564K	Sell	3,276 -2,435	-43%	-$410K	0.15%	89
2021 Q4	$1.45M	Buy	5,711 +48	+0.8%	+$14K	0.37%	66
2021 Q3	$2.18M	Buy	5,663 +902	+19%	+$333K	0.63%	47
2021 Q2	$1.12M	Buy	4,761 +281	+6%	+$50.2K	0.34%	61
2021 Q1	$587K	Buy	+4,480	New	+$649K	0.21%	79

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Xcel Wealth Management's MRNA Position: Q3 2026 in Review

Xcel Wealth Management opened a new position in Moderna (MRNA) in Q3 2026: 5,889 shares worth $1.13M. The stake represents 0.28% of the portfolio and ranks #68 among its holdings. This is a return to the name: Xcel Wealth Management previously reported a position in MRNA as recently as Q2 2023.

Xcel Wealth Management first reported a position in MRNA in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.18M in Q3 2021. 573 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

Xcel Wealth Management held 5,889 shares of Moderna worth $1.13M as of Q3 2026.
Moderna was a new Xcel Wealth Management position in Q3 2026.
Moderna made up 0.28% of Xcel Wealth Management's portfolio in Q3 2026, its #68 holding.
Xcel Wealth Management first reported a position in Moderna in Q1 2021 and has held it in 11 quarters since.
Xcel Wealth Management's Moderna position peaked at $2.18M in Q3 2021.
573 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Xcel Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.